Johnson & Johnson lifts dividend by 5.3% to $1.19/share
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
164,470$
0,12%
Echtzeit-Aktienkurs Johnson & Johnson
Bid:
Ask:
Nachrichten zur Johnson & Johnson Aktie
Johnson & Johnson beats Q1 consensus estimates and raises guidance
Johnson & Johnson’s stock JNJ rose 1.4% in premarket trade Tuesday, after the consumer health and pharma company beat consensus…
Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock up 1.9% premarket
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J talc unit again seeks to halt 38,000 cancer lawsuits
...By Dietrich Knauth
(Reuters) - A Johnson & Johnson subsidiary......…
Bank of America, Goldman Sachs, J&J, Netflix, and More Stock Market Movers
Bank of America, Goldman Sachs, and Johnson & Johnson are scheduled to report quarterly earnings before the stock market opens…
US-Berichtssaison: Es geht weiter!
Mit den Zahlenvorlagen von Netflix, Goldman Sachs, Johnson & Johnson und Bank of America findet die Berichtssaison am Dienstag eine…
Johnson & Johnson stock underperforms Monday when compared to competitors
Johnson & Johnson stock underperforms Monday when compared to competitors...…
Check Out What Whales Are Doing With JNJ
read more...…
Johnson & Johnson Q1 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Will J&J (JNJ) Pharma Unit Outperform Market & Drive Q1 Results?
In J&Js (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara is likely to have…
Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement?
The controversial company could soon take a big step forward....…
Why Johnson & Johnson Is Such an Impressive Dividend Stock
For dividend investors, this stock can be a solid pillar to build your portfolio around....…
Johnson & Johnson Stock: Bear vs. Bull
The stocks proponents are facing upcoming uncertainty, but its detractors arent as much....…
Johnson & Johnson stock outperforms market despite losses on the day
Johnson & Johnson stock outperforms market despite losses on the day...…
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News
Is now the time to buy the stock?...…
Johnson & Johnson stock outperforms competitors on strong trading day
Johnson & Johnson stock outperforms competitors on strong trading day...…
Johnson & Johnson stock falls Wednesday, still outperforms market
Johnson & Johnson stock falls Wednesday, still outperforms market...…
Check Out What Whales Are Doing With JNJ
read more...…
J&J talc unit faces skepticism on bankruptcy settlement support
...By Dietrich Knauth
(Reuters) - A Johnson & Johnson company......…
Johnson & Johnson stock falls Tuesday, underperforms market
Johnson & Johnson stock falls Tuesday, underperforms market...…
Johnson & Johnson talc victims seek dismissal of latest bankruptcy bid
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson: Babypuder krebserregend? US-Konzern akzeptiert einen Vergleich von 8,9 Mrd. USD - Aktiennews
Wien (www.aktiencheck.de) - Johnson & Johnson: Babypuder krebserregend? US-Konzern akzeptiert einen Vergleich von 8,9 Mrd. USD - Aktiennews
Johnson & Johnson…
Johnson & Johnson bietet acht Milliarden Euro für Vergleich - Krebsverdacht bei Babypuder
Es geht um Eierstockkrebs und um Asbestverdacht: Der Pharmakonzern Johnson & Johnson sieht sich in den USA mit 40.000 Klagen…
Is Johnson & Johnson About to Put Its Talc Lawsuits to Bed?
The company took an important step toward that goal....…
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Johnson & Johnson (JNJ) closed at $164.32, marking a -0.5% move from the previous day....…
Johnson & Johnson stock falls Monday, underperforms market
Johnson & Johnson stock falls Monday, underperforms market...…
AbbVie (ABBV), J&J to Withdraw 2 Blood Cancer Nods for Imbruvica
AbbVie (ABBV)/J&Js (JNJ) decision to withdraw the FDAs accelerated approval for Imbruvica in two blood cancer treatments is based on…
3 Things About Johnson & Johnson Smart Investors Know
The healthcare giants stock is looking like less of a safe bet than it was in the past....…
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to…
The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer
J&J, AstraZeneca, Merck, Seagen and Pfizer are part of the Zacks Top Analyst Blog....…
Exxon Mobil, Johnson & Johnson, Alphabet: Stocks That Defined the Week
Here are seven major companies whose stocks moved on the weeks news...…
Johnson & Johnson: "overweight"
San Francisco (www.aktiencheck.de) - Rating-Update:
Larry Biegelsen, Analyst von Wells Fargo Advisors, stuft die Aktie von Johnson & Johnson (J&J) (ISIN:…
Johnson & Johnson stock underperforms Thursday when compared to competitors
Johnson & Johnson stock underperforms Thursday when compared to competitors...…
Johnson & Johnson wins reimbursement for Rybrevant cancer therapy in Canada
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Look to 3 great American companies in this market, Jim Cramer says
There are three companies that Cramer thinks have compelling stories and strength: Johnson & Johnson, Eli Lilly, and Procter &…
Johnson & Johnson (JNJ) Soars 4.5%: Is Further Upside Left in the Stock?
Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The…
J&J, Walmart lift Dow in down day for US stocks
April 06, 2023 7:06 AMDow Jones Industrial Average climbs 0.2 per cent to 33,482.72....…
Why did Johnson & Johnson stock go up today? Renewed hope for talc settlements
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Health Care Up as J&J Rallies -- Health Care Roundup
Health Care Up as J&J Rallies -- Health Care Roundup...…
Johnson & Johnson stock outperforms competitors on strong trading day
Johnson & Johnson stock outperforms competitors on strong trading day...…
Why Johnson & Johnson Stock Was Climbing Today
The healthcare giant reached a $8.9 billion settlement over allegations that its baby powder caused cancer....…
J&J-Tochterfirma beantragt erneut Gläubigerschutz im Babypuder-Skandal
New York (Reuters) - Eine Tochterfirma des US-Pharma- und Konsumgüterherstellers Johnson & Johnson (J&J) hat im Skandal um mutmaßlich asbestverseuchtes…
Johnson & Johnson will 'Baby Powder'-Klagen mit Milliarden-Vergleich beilegen
NEW BRUNSWICK (dpa-AFX) - Der US-Pharmakonzern Johnson & Johnson (J&J) will einen großen Rechtsstreit um…
Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…
Johnson & Johnson verfehlt 2022 eigene Wachstumsziele
NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…
Johnson & Johnson: Aussichtsreicher HIV-Impfstoff schützt nicht
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
Johnson&Johnson-Sparte Kenvue stellt Antrag auf Börsennotierung
Bangalore (Reuters) - Die Consumer-Health-Sparte mit rezeptfreien Medikamenten und anderen Gesundheitsprodukten des US-Pharmakonzerns Johnson & Johnson (J&J) hat einen Antrag…
Gesundheitskonzern Johnson & Jonson spürt Gegenwind durch starken Dollar
NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…
US-Gesundheitskonzern Johnson & Johnson senkt wegen Dollarstärke Prognose
NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…